Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Dr. Timothy Mackey, Medical Director of NovaGenix

Am I a Candidate for TRT? Who Qualifies for Testosterone Therapy

September 18, 2026

A physician-reviewed guide to TRT candidacy: the two findings required for a diagnosis, why 300 ng/dL is not an automatic threshold, what delays or rules out treatment, and the conditions commonly mistaken for low testosterone.

Read More

Tesamorelin for Women: What the Evidence and FDA Label Actually Say

September 17, 2026

Can women use tesamorelin? A physician-reviewed look at what the FDA label and clinical trials actually say about abdominal fat, dosing, pregnancy, side effects and monitoring.

Read More
NovaGenix celebrates 10 years in Jupiter, Florida, 2016–2026

NovaGenix Celebrates 10 Years: A Decade of Care, Community and Connection

September 15, 2026

From a friendship formed through Brazilian jiu-jitsu to a physician-led practice in Jupiter, NovaGenix celebrates ten years of care, community and patient relationships.

Read More
Dr. Timothy Mackey, Medical Director of NovaGenix in Jupiter, Florida

Enclomiphene vs. TRT: Benefits, Fertility, Risks, and Cost

September 14, 2026

Compare two approaches to low testosterone, with a focus on fertility goals, symptom evidence, side effects, testing, and the complete cost of care.

Read More
College football player reviewing an eligibility warning with a sports physician near the stadium field

Kickoff Warning: Peptides, Steroids, and Why a College Football Season Can End Before Week 1

September 6, 2026

A physician-led guide to NCAA banned peptides, steroids, medical exceptions, supplement risk, and what athletes should verify before taking anything.

Read More
A middle-aged woman standing thoughtfully beside a sunlit window, representing the transition through perimenopause and menopause.

Perimenopause vs. Menopause: What's the Difference?

September 5, 2026

Perimenopause is a years-long transition; menopause is confirmed after 12 months without a period. Learn how symptoms, diagnosis, and treatment differ.

Read More
Timeline of the July 2026 FDA peptide advisory vote showing six of seven substances recommended for possible 503A-list inclusion; the vote was nonbinding and not drug approval.

What the July 2026 FDA Peptide Vote Actually Means for Patients

September 4, 2026

An FDA advisory committee recommended six peptide substances for possible 503A-list inclusion in July 2026. Here is what that nonbinding vote means—and what it does not mean—for patients.

Read More

Retatrutide: What It Is, What the Research Shows, and When You Can Get It

August 31, 2026

Retatrutide is an investigational triple agonist—not an FDA-approved medication. Learn what Phase 2 and Phase 3 research shows, known risks, and what patients can legally access today.

Read More
Timothy Mackey, D.O., answering common questions men ask before starting TRT

Considering TRT? 14 Questions Men Should Ask Before Starting Testosterone Therapy

August 28, 2026

A physician-led decision guide to 14 questions men should ask before TRT, including diagnosis, safety, fertility, cost, hidden fees, monitoring and provider selection.

Read More

Schedule a Consultation

Learn what you want to know about hormone therapy by scheduling a free consultation.

Contact Us Today
Location pin icon

609 N Hepburn Ave Ste 106, Jupiter, FL 33458